NCT04845984

Brief Summary

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 15, 2021

Completed
Last Updated

April 15, 2021

Status Verified

March 1, 2021

Enrollment Period

5 months

First QC Date

March 2, 2021

Last Update Submit

April 12, 2021

Conditions

Covid19Health Care Worker

Outcome Measures

Primary Outcomes (1)

  • SARS-CoV-2 prevalency among hospital health care professionals

    Number of Health Care Worker with an antibody test (IgG) positive for SARS-CoV2

    Day 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will be proposed to all the staff of participating hospitals, who have been tested for SARS-CoV-2 (serology) and who have not objected to the use of their health data.

You may qualify if:

  • Hospital staff employee
  • Employed in one of the participating centers
  • Volunteers to perform SARS-CoV-2 serology
  • Permanent or occasional staff (temporary workers, short contracts)
  • Caregivers or not (medical, paramedical, administrative, technical staff)

You may not qualify if:

  • Staff who are not working at a participating center while participating in the study
  • Person under guardianship or curatorship
  • Opposition to data collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ch Annecy Genevois

Pringy, 74374, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2021

First Posted

April 15, 2021

Study Start

September 1, 2020

Primary Completion

January 15, 2021

Study Completion

January 15, 2021

Last Updated

April 15, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)